Leadership & Pay ·
Prenetics names Brian J. Rosin successor CFO effective Dec. 31; Stephen Lo steps down
PRENWPrenetics Global Ltd
Prenetics Global Limited announced that Brian J. Rosin will succeed Stephen Hoi Chun Lo as Chief Financial Officer, effective December 31, 2026. The Board of Directors is expected to formalize the appointment at its meeting on November 12, 2026. Mr. Rosin, who joined as CFO of subsidiary IM8 in May 2026, will serve as CFO-designate through year-end before leading the global finance organization. Mr. Lo will remain with the company as a Senior Advisor following his departure from the CFO role. The transition consolidates finance leadership under a single U.S.-based executive as IM8 represents substantially all of Prenetics' revenue. Prenetics Global Limited operates in the consumer health and longevity sector, primarily through its flagship brand IM8.